Search

everythinglearnresearchcommunity

for

Search:↓

Nursing care is crucial for safe and effective hair transplants.

Routine eye exams may be needed for alopecia areata patients due to common eye issues.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Many people with skin conditions don't seek professional help, often due to self-management beliefs.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Pharmacist-led care significantly improved post-COVID symptoms.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Using hemocoagulase with platelet-rich plasma in hip replacement can lessen blood loss and improve healing and blood clotting.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

Anabolic-androgenic steroid abuse can cause heart damage and sudden death.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Lower doses of oral minoxidil can promote hair growth without major heart risks.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Premature canities is linked to low vitamin D and B12, family history, and higher MHR.

Many women with female pattern hair loss also have metabolic syndrome.

Genetic factors and diet significantly increase the risk of male pattern baldness.

People with type 2 diabetes have lower vitamin E levels, especially older adults and females.

PRP improves hair transplant results in androgenetic alopecia patients.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Classical PCOS types A and B are most common and linked to higher health risks.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.